SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2019-01-28
Tx date 2019-01-23
$ATT
Abattis Bioceuticals Corp.
Wilson, Cedric Paul
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market

-150,000 vol
0
Filed 2018-12-18
Tx date 2018-11-22
$ATT
Abattis Bioceuticals Corp.
Wilson, Cedric Paul
4 - Director of Issuer
Direct Ownership
Common Shares
46 - Compensation for services

+150,000 vol
150,000
Filed 2018-12-18
Tx date 2018-10-01
$ATT
Abattis Bioceuticals Corp.
Wilson, Cedric Paul
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2018-11-26
Tx date 2018-05-07
$ATT
Abattis Bioceuticals Corp.
McParland, Kent
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2018-11-26
Tx date 2018-11-22
$ATT
Abattis Bioceuticals Corp.
McParland, Kent
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
46 - Compensation for services
$13,500
+150,000 vol
$0.09 each
150,000
Filed 2018-10-23
Tx date 2018-09-28
$ATT
Abattis Bioceuticals Corp.
McParland, Kent
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
46 - Compensation for services
$13,500
+100,000 vol
$0.135 each
100,000
Filed 2018-10-23
Tx date 2018-05-07
$ATT
Abattis Bioceuticals Corp.
McParland, Kent
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2018-10-23
Tx date 2018-05-07
$ATT
Abattis Bioceuticals Corp.
McParland, Kent
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2018-10-23
Tx date 2018-06-21
$ATT
Abattis Bioceuticals Corp.
McParland, Kent
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$18,500
+100,000 vol
$0.185 each
100,000
Filed 2018-09-19
Tx date 2018-09-17
$ATT
Abattis Bioceuticals Corp.
David, Rene
5 - Senior Officer of Issuer
Direct Ownership
Warrants
54 - Exercise of warrants
$-30,000
-200,000 vol
$0.15 each
-65,000
Filed 2018-09-19
Tx date 2018-09-17
$ATT
Abattis Bioceuticals Corp.
David, Rene
5 - Senior Officer of Issuer
Direct Ownership
Warrants
55 - Expiration of warrants
$30,000
+200,000 vol
$0.15 each
135,000
Filed 2018-08-10
Tx date 2018-06-18
$ATT
Abattis Bioceuticals Corp.
Abenante, Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 1053345 B.C. Ltd. (Indirect Ownership)
Common Shares
16 - Acquisition or disposition under a prospectus exemption
$684,336
+4,677,625 vol
$0.1463 each
12,668,322
Filed 2018-08-08
Tx date 2018-04-26
$ATT
Abattis Bioceuticals Corp.
Richter, Wolfgang
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2018-08-08
Tx date 2018-04-26
$ATT
Abattis Bioceuticals Corp.
Richter, Wolfgang
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2018-08-08
Tx date 2018-04-26
$ATT
Abattis Bioceuticals Corp.
Richter, Wolfgang
4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2018-08-03
Tx date 2018-08-01
$ATT
Abattis Bioceuticals Corp.
Irving, James
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-35,400
-236,000 vol
$0.15 each
1,307,250
Filed 2018-06-27
Tx date 2018-06-26
$ATT
Abattis Bioceuticals Corp.
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services
$545,376
+4,277,465 vol
$0.1275 each
14,570,776
Filed 2018-06-27
Tx date 2018-06-26
$ATT
Abattis Bioceuticals Corp.
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services
$146,200
+1,000,000 vol
$0.1462 each
10,293,311
Filed 2018-06-21
Tx date 2018-06-19
$ATT
Abattis Bioceuticals Corp.
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
11 - Acquisition or disposition carried out privately
$-170,000
-1,000,000 vol
$0.17 each
9,293,311
Filed 2018-06-21
Tx date 2018-06-19
$ATT
Abattis Bioceuticals Corp.
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
47 - Acquisition or disposition by gift

-500,000 vol
10,293,311
Filed 2018-06-21
Tx date 2018-06-19
$ATT
Abattis Bioceuticals Corp.
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
47 - Acquisition or disposition by gift

-1,500,000 vol
Filed 2018-06-19
Tx date 2018-06-19
$ATT
Abattis Bioceuticals Corp.
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
47 - Acquisition or disposition by gift

-1,500,000 vol
9,293,311
Filed 2018-03-15
Tx date 2018-03-12
$ATT
Abattis Bioceuticals Corp.
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services
$810,000
+3,000,000 vol
$0.27 each
10,793,311
Filed 2018-03-14
Tx date 2018-03-12
$ATT
Abattis Bioceuticals Corp.
Boddy, Christina Lynn
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
46 - Compensation for services
$7,874
+29,166 vol
$0.27 each
160,970
Filed 2018-03-14
Tx date 2018-03-12
$ATT
Abattis Bioceuticals Corp.
Abenante, Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 1053345 B.C. Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services
$810,000
+3,000,000 vol
$0.27 each
7,990,697
Filed 2018-03-02
Tx date 2018-02-27
$ATT
Abattis Bioceuticals Corp.
Abenante, Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 1053345 B.C. Ltd. (Indirect Ownership)
Common Shares
47 - Acquisition or disposition by gift

-3,500,000 vol
4,990,697
Filed 2018-02-14
Tx date 2018-02-13
$ATT
Abattis Bioceuticals Corp.
David, Rene
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
46 - Compensation for services
$1,181,250
+4,500,000 vol
$0.2625 each
5,587,488
Filed 2018-02-14
Tx date 2018-02-13
$ATT
Abattis Bioceuticals Corp.
Abenante, Robert
5 - Senior Officer of Issuer
Holder: 1053345 B.C. Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services
$1,706,250
+6,500,000 vol
$0.2625 each
8,490,697
Filed 2018-01-22
Tx date 2018-01-19
$ATT
Abattis Bioceuticals Corp.
Panenka, William
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-53,100
-90,000 vol
$0.59 each
476,500
Filed 2018-01-22
Tx date 2018-01-18
$ATT
Abattis Bioceuticals Corp.
Panenka, William
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-53,100
-90,000 vol
$0.59 each
566,500
Filed 2018-01-18
Tx date 2018-01-16
$ATT
Abattis Bioceuticals Corp.
Panenka, William
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-16,750
-25,000 vol
$0.67 each
656,500
Filed 2018-01-18
Tx date 2018-01-16
$ATT
Abattis Bioceuticals Corp.
Panenka, William
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-43,771
-65,000 vol
$0.67 each
681,500
Filed 2018-01-17
Tx date 2018-01-16
$ATT
Abattis Bioceuticals Corp.
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services
$122,743
+762,379 vol
$0.161 each
7,793,311
Filed 2018-01-16
Tx date 2018-01-12
$ATT
Abattis Bioceuticals Corp.
Panenka, William
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-47,700
-90,000 vol
$0.53 each
836,500
Filed 2018-01-16
Tx date 2018-01-15
$ATT
Abattis Bioceuticals Corp.
Panenka, William
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-53,100
-90,000 vol
$0.59 each
746,500
Filed 2018-01-16
Tx date 2018-01-12
$ATT
Abattis Bioceuticals Corp.
Panenka, William
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-48,042
-90,000 vol
$0.53 each
926,500
Filed 2018-01-16
Tx date 2018-01-11
$ATT
Abattis Bioceuticals Corp.
Panenka, William
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-18,300
-30,000 vol
$0.61 each
1,016,500
Filed 2018-01-16
Tx date 2018-01-11
$ATT
Abattis Bioceuticals Corp.
Panenka, William
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-36,000
-60,000 vol
$0.60 each
1,046,500
Filed 2018-01-08
Tx date 2018-01-05
$ATT
Abattis Bioceuticals Corp.
Panenka, William
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-3,060
-4,500 vol
$0.68 each
1,106,500
Filed 2018-01-08
Tx date 2018-01-05
$ATT
Abattis Bioceuticals Corp.
Panenka, William
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-57,652.65
-85,500 vol
$0.67 each
1,111,000
Filed 2018-01-08
Tx date 2018-01-04
$ATT
Abattis Bioceuticals Corp.
Panenka, William
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-64,800
-90,000 vol
$0.72 each
1,196,500
Filed 2018-01-03
Tx date 2018-01-02
$ATT
Abattis Bioceuticals Corp.
Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-31,500
-50,000 vol
$0.63 each
42,971
Filed 2018-01-03
Tx date 2018-01-02
$ATT
Abattis Bioceuticals Corp.
Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-30,500
-50,000 vol
$0.61 each
92,971
Filed 2018-01-03
Tx date 2018-01-02
$ATT
Abattis Bioceuticals Corp.
Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-29,500
-50,000 vol
$0.59 each
142,971
Filed 2018-01-03
Tx date 2018-01-02
$ATT
Abattis Bioceuticals Corp.
Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-28,500
-50,000 vol
$0.57 each
192,971
Filed 2018-01-03
Tx date 2018-01-02
$ATT
Abattis Bioceuticals Corp.
Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-168,000
-300,000 vol
$0.56 each
242,971
Filed 2018-01-03
Tx date 2018-01-02
$ATT
Abattis Bioceuticals Corp.
Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-27,500
-50,000 vol
$0.55 each
542,971
Filed 2018-01-02
Tx date 2017-12-27
$ATT
Abattis Bioceuticals Corp.
Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-14,575
-26,500 vol
$0.55 each
592,971
Filed 2017-12-21
Tx date 2017-12-20
$ATT
Abattis Bioceuticals Corp.
Gordon, Peter Vicars
4 - Director of Issuer
Holder: P V Gordon Holdings Ltd. (Indirect Ownership)
Options
51 - Exercise of options

-133,333 vol
66,667
Filed 2017-12-21
Tx date 2017-12-20
$ATT
Abattis Bioceuticals Corp.
Gordon, Peter Vicars
4 - Director of Issuer
Holder: P V Gordon Holdings Ltd. (Indirect Ownership)
Common Shares
51 - Exercise of options
$19,333
+133,333 vol
$0.145 each
535,889
Filed 2017-12-20
Tx date 2017-12-18
$ATT
Abattis Bioceuticals Corp.
Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services
$20,999
+48,837 vol
$0.43 each
619,471
Filed 2017-12-20
Tx date 2017-12-18
$ATT
Abattis Bioceuticals Corp.
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services
$15,749
+36,627 vol
$0.43 each
7,030,932
Filed 2017-12-20
Tx date 2017-12-18
$ATT
Abattis Bioceuticals Corp.
Boddy, Christina Lynn
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
46 - Compensation for services
$6,299
+14,651 vol
$0.43 each
131,804
Filed 2017-12-20
Tx date 2017-12-18
$ATT
Abattis Bioceuticals Corp.
Abenante, Robert
5 - Senior Officer of Issuer
Holder: 1053345 B.C. Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services
$15,350
+35,698 vol
$0.43 each
1,990,697
Filed 2017-12-19
Tx date 2017-12-15
$ATT
Abattis Bioceuticals Corp.
Gordon, Peter Vicars
4 - Director of Issuer
Holder: P V Gordon Holdings Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-55,000
-100,000 vol
$0.55 each
402,556
Filed 2017-12-19
Tx date 2017-12-18
$ATT
Abattis Bioceuticals Corp.
David, Rene
5 - Senior Officer of Issuer
Direct Ownership
Warrants
54 - Exercise of warrants

-200,000 vol
135,000
Filed 2017-12-19
Tx date 2017-12-18
$ATT
Abattis Bioceuticals Corp.
David, Rene
5 - Senior Officer of Issuer
Direct Ownership
Warrants
54 - Exercise of warrants

+200,000 vol
335,000
Filed 2017-12-18
Tx date 2017-12-15
$ATT
Abattis Bioceuticals Corp.
Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-33,000
-50,000 vol
$0.66 each
570,634
Filed 2017-12-18
Tx date 2017-12-14
$ATT
Abattis Bioceuticals Corp.
Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-18,427.50
-40,500 vol
$0.455 each
620,634
Filed 2017-12-18
Tx date 2017-12-14
$ATT
Abattis Bioceuticals Corp.
Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-15,250
-50,000 vol
$0.305 each
661,134
Filed 2017-12-18
Tx date 2017-12-14
$ATT
Abattis Bioceuticals Corp.
Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-24,500
-50,000 vol
$0.49 each
711,134
Filed 2017-12-18
Tx date 2017-12-14
$ATT
Abattis Bioceuticals Corp.
Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-23,500
-50,000 vol
$0.47 each
761,134
Filed 2017-12-18
Tx date 2017-12-14
$ATT
Abattis Bioceuticals Corp.
Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-4,370
-9,500 vol
$0.46 each
811,134
Filed 2017-12-18
Tx date 2017-12-14
$ATT
Abattis Bioceuticals Corp.
Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-16,500
-50,000 vol
$0.33 each
820,634
Filed 2017-12-18
Tx date 2017-12-14
$ATT
Abattis Bioceuticals Corp.
Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-12,800
-40,000 vol
$0.32 each
870,634
Filed 2017-12-18
Tx date 2017-12-14
$ATT
Abattis Bioceuticals Corp.
Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-15,750
-50,000 vol
$0.315 each
910,634
Filed 2017-12-15
Tx date 2017-12-13
$ATT
Abattis Bioceuticals Corp.
Irving, James
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-70,000
-100,000 vol
$0.70 each
1,543,250
Filed 2017-12-15
Tx date 2017-12-12
$ATT
Abattis Bioceuticals Corp.
Irving, James
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-20,500
-50,000 vol
$0.41 each
1,643,250
Filed 2017-12-15
Tx date 2017-12-12
$ATT
Abattis Bioceuticals Corp.
Irving, James
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-23,000
-50,000 vol
$0.46 each
1,693,250
Filed 2017-12-13
Tx date 2017-12-12
$ATT
Abattis Bioceuticals Corp.
David, Rene
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-30,360
-66,000 vol
$0.46 each
1,087,488
Filed 2017-12-13
Tx date 2017-12-12
$ATT
Abattis Bioceuticals Corp.
Panenka, William
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-48,000
-100,000 vol
$0.48 each
1,286,500
Filed 2017-12-13
Tx date 2017-12-12
$ATT
Abattis Bioceuticals Corp.
Panenka, William
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-27,000
-50,000 vol
$0.54 each
1,386,500
Filed 2017-12-13
Tx date 2017-12-12
$ATT
Abattis Bioceuticals Corp.
Panenka, William
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-50,000
-100,000 vol
$0.50 each
1,436,500
Filed 2017-12-06
Tx date 2017-12-06
$ATT
Abattis Bioceuticals Corp.
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
47 - Acquisition or disposition by gift

-1,046,667 vol
6,994,305
Filed 2017-11-29
Tx date 2017-11-28
$ATT
Abattis Bioceuticals Corp.
Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-3,200
-10,000 vol
$0.32 each
960,634
Filed 2017-11-29
Tx date 2017-11-28
$ATT
Abattis Bioceuticals Corp.
Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-15,750
-50,000 vol
$0.315 each
970,634
Filed 2017-11-29
Tx date 2017-11-27
$ATT
Abattis Bioceuticals Corp.
Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-14,000
-50,000 vol
$0.28 each
1,020,634
Filed 2017-11-29
Tx date 2017-11-27
$ATT
Abattis Bioceuticals Corp.
Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-24,500
-100,000 vol
$0.245 each
1,070,634
Filed 2017-11-29
Tx date 2017-11-27
$ATT
Abattis Bioceuticals Corp.
Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-14,500
-50,000 vol
$0.29 each
1,170,634
Filed 2017-11-29
Tx date 2017-11-27
$ATT
Abattis Bioceuticals Corp.
Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-14,250
-50,000 vol
$0.285 each
1,220,634
Filed 2017-11-29
Tx date 2017-11-27
$ATT
Abattis Bioceuticals Corp.
Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-13,750
-50,000 vol
$0.275 each
1,270,634
Filed 2017-11-29
Tx date 2017-11-27
$ATT
Abattis Bioceuticals Corp.
Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-13,250
-50,000 vol
$0.265 each
1,320,634
Filed 2017-11-27
Tx date 2017-11-24
$ATT
Abattis Bioceuticals Corp.
Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-11,500
-50,000 vol
$0.23 each
1,370,634
Filed 2017-11-27
Tx date 2017-11-24
$ATT
Abattis Bioceuticals Corp.
Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-11,250
-50,000 vol
$0.225 each
1,420,634
Filed 2017-11-27
Tx date 2017-11-23
$ATT
Abattis Bioceuticals Corp.
Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-11,250
-50,000 vol
$0.225 each
1,470,634
Filed 2017-11-27
Tx date 2017-11-22
$ATT
Abattis Bioceuticals Corp.
Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-5,405
-23,500 vol
$0.23 each
1,520,634
Filed 2017-11-27
Tx date 2017-11-22
$ATT
Abattis Bioceuticals Corp.
Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-22,500
-100,000 vol
$0.225 each
1,544,134
Filed 2017-11-27
Tx date 2017-11-22
$ATT
Abattis Bioceuticals Corp.
Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-11,500
-50,000 vol
$0.23 each
1,644,134
Filed 2017-11-08
Tx date 2017-11-06
$ATT
Abattis Bioceuticals Corp.
Irving, James
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-18,275
-107,500 vol
$0.17 each
1,743,250
Filed 2017-11-01
Tx date 2017-10-30
$ATT
Abattis Bioceuticals Corp.
Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services
$7,352
+52,972 vol
$0.1388 each
1,694,134
Filed 2017-11-01
Tx date 2017-10-30
$ATT
Abattis Bioceuticals Corp.
Boddy, Christina Lynn
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
46 - Compensation for services
$3,151
+22,702 vol
$0.1388 each
117,153
Filed 2017-11-01
Tx date 2017-10-30
$ATT
Abattis Bioceuticals Corp.
Abenante, Robert
5 - Senior Officer of Issuer
Holder: 1053345 B.C. Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services
$7,788
+56,116 vol
$0.1388 each
1,954,999
Filed 2017-11-01
Tx date 2017-10-03
$ATT
Abattis Bioceuticals Corp.
Abenante, Robert
5 - Senior Officer of Issuer
Holder: 1053345 B.C. Ltd. (Indirect Ownership)
Common Shares
11 - Acquisition or disposition carried out privately

-27,586 vol
1,898,883
Filed 2017-10-31
Tx date 2017-10-30
$ATT
Abattis Bioceuticals Corp.
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services
$13,745
+99,099 vol
$0.1387 each
8,040,972
Filed 2017-09-12
Tx date 2017-09-10
$ATT
Abattis Bioceuticals Corp.
Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Options
50 - Grant of options

+200,000 vol
200,000
Filed 2017-09-12
Tx date 2016-11-14
$ATT
Abattis Bioceuticals Corp.
Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Options
00 - Opening Balance-Initial SEDI Report
Filed 2017-09-12
Tx date 2017-09-08
$ATT
Abattis Bioceuticals Corp.
Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services
$10,504
+96,551 vol
$0.1088 each
1,641,162
Filed 2017-09-12
Tx date 2017-09-10
$ATT
Abattis Bioceuticals Corp.
Panenka, William
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+200,000 vol
200,000
Filed 2017-09-12
Tx date 2016-11-02
$ATT
Abattis Bioceuticals Corp.
Panenka, William
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2017-09-12
Tx date 2017-09-10
$ATT
Abattis Bioceuticals Corp.
Irving, James
4 - Director of Issuer
Holder: Jim Irving Consulting (Indirect Ownership)
Options
50 - Grant of options

+200,000 vol
200,000
Filed 2017-09-12
Tx date 2015-09-16
$ATT
Abattis Bioceuticals Corp.
Irving, James
4 - Director of Issuer
Holder: Jim Irving Consulting (Indirect Ownership)
Options
00 - Opening Balance-Initial SEDI Report
Filed 2017-09-12
Tx date 2017-09-11
$ATT
Abattis Bioceuticals Corp.
Irving, James
4 - Director of Issuer
Holder: Jim Irving Consulting (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-6,750
-45,000 vol
$0.15 each
36,159
Filed 2017-09-12
Tx date 2017-09-10
$ATT
Abattis Bioceuticals Corp.
Gordon, Peter Vicars
4 - Director of Issuer
Holder: P V Gordon Holdings Ltd. (Indirect Ownership)
Options
50 - Grant of options

+200,000 vol
200,000
Filed 2017-09-12
Tx date 2017-05-29
$ATT
Abattis Bioceuticals Corp.
Gordon, Peter Vicars
4 - Director of Issuer
Holder: P V Gordon Holdings Ltd. (Indirect Ownership)
Options
00 - Opening Balance-Initial SEDI Report
Filed 2017-09-12
Tx date 2017-09-11
$ATT
Abattis Bioceuticals Corp.
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Options
50 - Grant of options
$145,000
+1,000,000 vol
$0.145 each
2,885,000
Filed 2017-09-12
Tx date 2017-09-11
$ATT
Abattis Bioceuticals Corp.
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services
$5,247
+48,275 vol
$0.1087 each
7,941,873
Filed 2017-09-12
Tx date 2017-09-11
$ATT
Abattis Bioceuticals Corp.
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services
$14,499
+100,000 vol
$0.145 each
7,893,598
Filed 2017-09-12
Tx date 2017-09-10
$ATT
Abattis Bioceuticals Corp.
Boddy, Christina Lynn
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+25,000 vol
25,000
Filed 2017-09-12
Tx date 2017-06-12
$ATT
Abattis Bioceuticals Corp.
Boddy, Christina Lynn
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2017-09-12
Tx date 2017-09-08
$ATT
Abattis Bioceuticals Corp.
Boddy, Christina Lynn
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
46 - Compensation for services
$3,151
+28,965 vol
$0.1088 each
94,451
Filed 2017-09-12
Tx date 2017-09-10
$ATT
Abattis Bioceuticals Corp.
Abenante, Robert
5 - Senior Officer of Issuer
Holder: 1053345 B.C. Ltd. (Indirect Ownership)
Options
50 - Grant of options

+1,000,000 vol
1,000,000
Filed 2017-09-12
Tx date 2017-04-10
$ATT
Abattis Bioceuticals Corp.
Abenante, Robert
5 - Senior Officer of Issuer
Holder: 1053345 B.C. Ltd. (Indirect Ownership)
Options
00 - Opening Balance-Initial SEDI Report
Filed 2017-09-12
Tx date 2017-09-08
$ATT
Abattis Bioceuticals Corp.
Abenante, Robert
5 - Senior Officer of Issuer
Holder: 1053345 B.C. Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services
$15,757
+144,827 vol
$0.1088 each
1,926,469
Filed 2017-08-30
Tx date 2017-08-24
$ATT
Abattis Bioceuticals Corp.
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
47 - Acquisition or disposition by gift

-200,000 vol
7,793,598
Filed 2017-08-30
Tx date 2017-08-24
$ATT
Abattis Bioceuticals Corp.
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services
$23,000
+200,000 vol
$0.115 each
7,993,598
Filed 2017-08-30
Tx date 2017-08-24
$ATT
Abattis Bioceuticals Corp.
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services
$5,246
+60,869 vol
$0.0862 each
7,793,598
Filed 2017-08-23
Tx date 2017-08-21
$ATT
Abattis Bioceuticals Corp.
Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services
$10,493
+121,739 vol
$0.0862 each
1,544,611
Filed 2017-08-23
Tx date 2017-08-21
$ATT
Abattis Bioceuticals Corp.
Irving, James
4 - Director of Issuer
Holder: Jim Irving Consulting (Indirect Ownership)
Common Shares
46 - Compensation for services
$6,995
+81,159 vol
$0.0862 each
81,159
Filed 2017-08-23
Tx date 2015-09-16
$ATT
Abattis Bioceuticals Corp.
Irving, James
4 - Director of Issuer
Holder: Jim Irving Consulting (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2017-08-23
Tx date 2017-08-21
$ATT
Abattis Bioceuticals Corp.
Boddy, Christina Lynn
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
46 - Compensation for services
$3,148
+36,521 vol
$0.0862 each
65,486
Filed 2017-08-23
Tx date 2017-08-21
$ATT
Abattis Bioceuticals Corp.
Abenante, Robert
5 - Senior Officer of Issuer
Holder: 1053345 B.C. Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services
$13,358
+154,968 vol
$0.0862 each
1,781,642
Filed 2017-07-17
Tx date 2017-07-12
$ATT
Abattis Bioceuticals Corp.
Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services
$36,250
+250,000 vol
$0.145 each
1,422,872
Filed 2017-07-17
Tx date 2017-07-12
$ATT
Abattis Bioceuticals Corp.
Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services
$10,504
+96,551 vol
$0.1088 each
1,172,872
Filed 2017-07-17
Tx date 2017-07-12
$ATT
Abattis Bioceuticals Corp.
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services
$5,247
+48,275 vol
$0.1087 each
7,732,729
Filed 2017-07-17
Tx date 2017-07-12
$ATT
Abattis Bioceuticals Corp.
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services
$72,500
+500,000 vol
$0.145 each
7,684,454
Filed 2017-07-17
Tx date 2017-07-12
$ATT
Abattis Bioceuticals Corp.
Boddy, Christina Lynn
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
46 - Compensation for services
$3,151
+28,965 vol
$0.1088 each
28,965
Filed 2017-07-17
Tx date 2017-06-12
$ATT
Abattis Bioceuticals Corp.
Boddy, Christina Lynn
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2017-07-17
Tx date 2017-07-12
$ATT
Abattis Bioceuticals Corp.
Abenante, Robert
5 - Senior Officer of Issuer
Holder: 1053345 B.C. Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services
$72,500
+500,000 vol
$0.145 each
1,626,674
Filed 2017-07-17
Tx date 2017-07-12
$ATT
Abattis Bioceuticals Corp.
Abenante, Robert
5 - Senior Officer of Issuer
Holder: 1053345 B.C. Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services
$13,506
+124,137 vol
$0.1088 each
1,126,674
Filed 2017-06-21
Tx date 2017-06-15
$ATT
Abattis Bioceuticals Corp.
Irving, James
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$-48,000
-300,000 vol
$0.16 each
1,850,750
Filed 2017-06-21
Tx date 2017-06-16
$ATT
Abattis Bioceuticals Corp.
Gordon, Peter Vicars
4 - Director of Issuer
Holder: P V Gordon Holdings Ltd. (Control or Direction)
Common Shares
46 - Compensation for services
$92,500
+500,000 vol
$0.185 each
502,556
Filed 2017-06-21
Tx date 2017-05-29
$ATT
Abattis Bioceuticals Corp.
Gordon, Peter Vicars
4 - Director of Issuer
Holder: P V Gordon Holdings Ltd. (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report
2,556
Filed 2017-06-17
Tx date 2017-06-12
$ATT
Abattis Bioceuticals Corp.
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
11 - Acquisition or disposition carried out privately
$-92,500
-500,000 vol
$0.185 each
7,184,454
Filed 2017-06-17
Tx date 2017-06-12
$ATT
Abattis Bioceuticals Corp.
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services
$92,500
+500,000 vol
$0.185 each
7,684,454
Filed 2017-06-15
Tx date 2017-06-12
$ATT
Abattis Bioceuticals Corp.
Irving, James
4 - Director of Issuer
Direct Ownership
Common Shares
46 - Compensation for services
$92,500
+500,000 vol
$0.185 each
2,150,750
Filed 2017-06-15
Tx date 2017-06-12
$ATT
Abattis Bioceuticals Corp.
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services
$5,247
+37,837 vol
$0.1387 each
7,184,454
Filed 2017-06-15
Tx date 2017-06-12
$ATT
Abattis Bioceuticals Corp.
Abenante, Robert
5 - Senior Officer of Issuer
Holder: 1053345 B.C. Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services
$92,500
+500,000 vol
$0.185 each
1,002,537
Filed 2017-06-15
Tx date 2017-06-12
$ATT
Abattis Bioceuticals Corp.
Abenante, Robert
5 - Senior Officer of Issuer
Holder: 1053345 B.C. Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services
$10,443
+75,675 vol
$0.138 each
502,537
Filed 2017-06-14
Tx date 2017-06-12
$ATT
Abattis Bioceuticals Corp.
Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services
$46,250
+250,000 vol
$0.185 each
1,076,321
Filed 2017-06-14
Tx date 2017-06-12
$ATT
Abattis Bioceuticals Corp.
Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services
$10,503
+75,675 vol
$0.1388 each
826,321
Filed 2017-06-14
Tx date 2017-06-12
$ATT
Abattis Bioceuticals Corp.
Panenka, William
4 - Director of Issuer
Direct Ownership
Common Shares
46 - Compensation for services
$92,500
+500,000 vol
$0.185 each
1,536,500
Filed 2017-06-14
Tx date 2017-06-12
$ATT
Abattis Bioceuticals Corp.
Irving, James
4 - Director of Issuer
Direct Ownership
Common Shares
46 - Compensation for services
$92,500
+500,000 vol
$0.185 each
1,650,750
Filed 2017-06-14
Tx date 2017-06-12
$ATT
Abattis Bioceuticals Corp.
Irving, James
4 - Director of Issuer
Direct Ownership
Common Shares
46 - Compensation for services
$92,500
+500,000 vol
$0.185 each
Filed 2017-06-06
Tx date 2017-04-28
$ATT
Abattis Bioceuticals Corp.
Abenante, Robert
5 - Senior Officer of Issuer
Holder: 1053345 B.C. Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services
$15,750
+87,500 vol
$0.18 each
426,862
Filed 2017-05-25
Tx date 2017-05-19
$ATT
Abattis Bioceuticals Corp.
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-20,500
-100,000 vol
$0.205 each
169,191
Filed 2017-05-12
Tx date 2017-05-08
$ATT
Abattis Bioceuticals Corp.
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-14,960
-68,000 vol
$0.22 each
269,191
Filed 2017-05-12
Tx date 2017-05-08
$ATT
Abattis Bioceuticals Corp.
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-16,560
-72,000 vol
$0.23 each
337,191
Filed 2017-05-05
Tx date 2017-05-02
$ATT
Abattis Bioceuticals Corp.
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-18,000
-300,000 vol
$0.06 each
150,000
Filed 2017-05-05
Tx date 2017-05-02
$ATT
Abattis Bioceuticals Corp.
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$18,000
+300,000 vol
$0.06 each
409,191
Filed 2017-05-04
Tx date 2017-05-02
$ATT
Abattis Bioceuticals Corp.
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-23,500
-100,000 vol
$0.235 each
109,191
Filed 2017-05-04
Tx date 2017-05-02
$ATT
Abattis Bioceuticals Corp.
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-23,140
-100,000 vol
$0.2314 each
209,191
Filed 2017-05-04
Tx date 2017-05-02
$ATT
Abattis Bioceuticals Corp.
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-12,750
-50,000 vol
$0.255 each
309,191
Filed 2017-05-04
Tx date 2017-05-02
$ATT
Abattis Bioceuticals Corp.
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-12,500
-50,000 vol
$0.25 each
359,191
Filed 2017-04-26
Tx date 2017-04-20
$ATT
Abattis Bioceuticals Corp.
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-27,230
-100,000 vol
$0.2723 each
409,191
Filed 2017-04-26
Tx date 2017-04-06
$ATT
Abattis Bioceuticals Corp.
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-5,125
-25,000 vol
$0.205 each
509,191
Filed 2017-04-26
Tx date 2017-04-05
$ATT
Abattis Bioceuticals Corp.
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-30,750
-150,000 vol
$0.205 each
534,191
Filed 2017-04-26
Tx date 2017-04-05
$ATT
Abattis Bioceuticals Corp.
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-15,375
-75,000 vol
$0.205 each
684,191
Filed 2017-04-26
Tx date 2017-04-04
$ATT
Abattis Bioceuticals Corp.
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-10,250
-50,000 vol
$0.205 each
759,191
Filed 2017-04-26
Tx date 2017-04-04
$ATT
Abattis Bioceuticals Corp.
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-10,370
-50,000 vol
$0.2074 each
809,191
Filed 2017-04-26
Tx date 2017-04-04
$ATT
Abattis Bioceuticals Corp.
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-86.00
-430 vol
$0.20 each
859,191
Filed 2017-04-26
Tx date 2017-04-03
$ATT
Abattis Bioceuticals Corp.
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-8,500
-50,000 vol
$0.17 each
859,621
Filed 2017-04-26
Tx date 2017-04-03
$ATT
Abattis Bioceuticals Corp.
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-12,862.50
-73,500 vol
$0.175 each
909,621
Filed 2017-04-26
Tx date 2017-04-03
$ATT
Abattis Bioceuticals Corp.
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-9,250
-50,000 vol
$0.185 each
983,121
Filed 2017-04-26
Tx date 2017-04-03
$ATT
Abattis Bioceuticals Corp.
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-4,770
-26,500 vol
$0.18 each
1,033,121
Filed 2017-04-25
Tx date 2012-08-21
$ATT
Abattis Bioceuticals Corp.
Sorocco, Douglas
4 - Director of Issuer
Direct Ownership
Common Shares
46 - Compensation for services

+50,000 vol
Filed 2017-04-25
Tx date 2012-08-21
$ATT
Abattis Bioceuticals Corp.
Sorocco, Douglas
4 - Director of Issuer
Direct Ownership
Common Shares
46 - Compensation for services

+50,000 vol
Filed 2017-04-25
Tx date 2017-04-20
$ATT
Abattis Bioceuticals Corp.
David, Rene
5 - Senior Officer of Issuer
Direct Ownership
Warrants
54 - Exercise of warrants

-65,000 vol
135,000
Filed 2017-04-25
Tx date 2015-03-11
$ATT
Abattis Bioceuticals Corp.
David, Rene
5 - Senior Officer of Issuer
Direct Ownership
Warrants
15 - Acquisition or disposition under a prospectus

+200,000 vol
200,000
Filed 2017-04-25
Tx date 2017-04-20
$ATT
Abattis Bioceuticals Corp.
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services
$117,966
+669,504 vol
$0.1762 each
7,146,617
Filed 2017-04-25
Tx date 2015-03-17
$ATT
Abattis Bioceuticals Corp.
David, Rene
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption
$26,000
+200,000 vol
$0.13 each
1,053,488
Filed 2017-04-25
Tx date 2017-04-20
$ATT
Abattis Bioceuticals Corp.
Abenante, Robert
5 - Senior Officer of Issuer
Holder: 1053345 B.C. Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services

+339,362 vol
339,362
Filed 2017-04-25
Tx date 2017-04-10
$ATT
Abattis Bioceuticals Corp.
Abenante, Robert
5 - Senior Officer of Issuer
Holder: 1053345 B.C. Ltd. (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2017-04-17
Tx date 2017-04-13
$ATT
Abattis Bioceuticals Corp.
Panenka, William
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-21,315
-73,500 vol
$0.29 each
1,036,500
Filed 2017-04-16
Tx date 2017-04-12
$ATT
Abattis Bioceuticals Corp.
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services
$80,250
+535,000 vol
$0.15 each
6,477,113
Filed 2017-04-15
Tx date 2017-04-05
$ATT
Abattis Bioceuticals Corp.
Irving, James
4 - Director of Issuer
Direct Ownership
Common Shares
46 - Compensation for services
$93,000
+600,000 vol
$0.155 each
1,150,750
Filed 2017-04-15
Tx date 2017-04-05
$ATT
Abattis Bioceuticals Corp.
Irving, James
4 - Director of Issuer
Direct Ownership
Common Shares
46 - Compensation for services
$75,000
+500,000 vol
$0.15 each
Filed 2017-04-15
Tx date 2017-03-30
$ATT
Abattis Bioceuticals Corp.
Irving, James
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-9,675
-45,000 vol
$0.215 each
705,750
Filed 2017-04-15
Tx date 2017-03-30
$ATT
Abattis Bioceuticals Corp.
Irving, James
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-9,450
-45,000 vol
$0.21 each
Filed 2017-04-10
Tx date 2017-04-05
$ATT
Abattis Bioceuticals Corp.
Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Control or Direction)
Common Shares
46 - Compensation for services
$75,000
+500,000 vol
$0.15 each
680,646
Filed 2017-04-10
Tx date 2017-04-05
$ATT
Abattis Bioceuticals Corp.
Panenka, William
4 - Director of Issuer
Direct Ownership
Common Shares
46 - Compensation for services
$75,000
+500,000 vol
$0.15 each
1,110,000
Filed 2017-04-10
Tx date 2017-04-05
$ATT
Abattis Bioceuticals Corp.
Irving, James
4 - Director of Issuer
Direct Ownership
Common Shares
46 - Compensation for services
$75,000
+500,000 vol
$0.15 each
1,050,750
Filed 2017-04-10
Tx date 2017-04-05
$ATT
Abattis Bioceuticals Corp.
Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Control or Direction)
Common Shares
46 - Compensation for services
$10,500
+70,000 vol
$0.15 each
750,646
Filed 2017-04-05
Tx date 2012-08-21
$ATT
Abattis Bioceuticals Corp.
Sorocco, Douglas
4 - Director of Issuer
Direct Ownership
Common Shares
46 - Compensation for services
$20,000
+250,000 vol
$0.08 each
300,000
Filed 2017-04-03
Tx date 2017-03-31
$ATT
Abattis Bioceuticals Corp.
Irving, James
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-31,000
-155,000 vol
$0.20 each
550,750
Filed 2017-04-03
Tx date 2017-03-30
$ATT
Abattis Bioceuticals Corp.
Irving, James
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-9,450
-45,000 vol
$0.21 each
705,750
Filed 2017-04-03
Tx date 2017-03-24
$ATT
Abattis Bioceuticals Corp.
Irving, James
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-6,900
-60,000 vol
$0.115 each
750,750
Filed 2017-04-03
Tx date 2017-03-24
$ATT
Abattis Bioceuticals Corp.
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Common Shares
46 - Compensation for services
$90,000
+750,000 vol
$0.12 each
1,059,621
Filed 2017-03-31
Tx date 2017-03-30
$ATT
Abattis Bioceuticals Corp.
Panenka, William
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-17,550
-90,000 vol
$0.195 each
610,000
Filed 2017-03-28
Tx date 2017-03-24
$ATT
Abattis Bioceuticals Corp.
Sorocco, Douglas
4 - Director of Issuer
Direct Ownership
Common Shares
46 - Compensation for services
$90,000
+750,000 vol
$0.12 each
868,400
Filed 2017-03-27
Tx date 2017-03-24
$ATT
Abattis Bioceuticals Corp.
Panenka, William
4 - Director of Issuer
Direct Ownership
Common Shares
46 - Compensation for services
$60,000
+500,000 vol
$0.12 each
700,000
Filed 2017-03-27
Tx date 2017-03-24
$ATT
Abattis Bioceuticals Corp.
Irving, James
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-9,300
-60,000 vol
$0.155 each
60,750
Filed 2017-03-27
Tx date 2017-03-24
$ATT
Abattis Bioceuticals Corp.
Irving, James
4 - Director of Issuer
Direct Ownership
Common Shares
46 - Compensation for services
$90,000
+750,000 vol
$0.12 each
810,750
Filed 2017-03-27
Tx date 2017-03-24
$ATT
Abattis Bioceuticals Corp.
Xie, Shuang
4 - Director of Issuer
Direct Ownership
Common Shares
46 - Compensation for services
$60,000
+500,000 vol
$0.12 each
892,687
Filed 2017-03-15
Tx date 2017-03-10
$ATT
Abattis Bioceuticals Corp.
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Options
51 - Exercise of options
$42,000
+700,000 vol
$0.06 each
1,750,000
Filed 2017-03-15
Tx date 2017-03-10
$ATT
Abattis Bioceuticals Corp.
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Options
51 - Exercise of options
$-42,000
-700,000 vol
$0.06 each
1,050,000
Filed 2017-03-15
Tx date 2017-03-13
$ATT
Abattis Bioceuticals Corp.
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services
$10,504
+90,322 vol
$0.1163 each
5,942,113
Filed 2017-03-15
Tx date 2017-03-10
$ATT
Abattis Bioceuticals Corp.
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-13,175
-85,000 vol
$0.155 each
5,851,791
Filed 2017-03-15
Tx date 2017-03-10
$ATT
Abattis Bioceuticals Corp.
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-30,000
-200,000 vol
$0.15 each
5,936,791
Filed 2017-03-14
Tx date 2017-03-13
$ATT
Abattis Bioceuticals Corp.
Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services
$21,009
+180,646 vol
$0.1163 each
180,646
Filed 2017-03-14
Tx date 2016-11-14
$ATT
Abattis Bioceuticals Corp.
Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2017-03-06
Tx date 2017-03-03
$ATT
Abattis Bioceuticals Corp.
Xie, Shuang
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-26,021.325
-157,705 vol
$0.165 each
392,687
Filed 2017-01-27
Tx date 2017-01-18
$ATT
Abattis Bioceuticals Corp.
Panenka, William
4 - Director of Issuer
Direct Ownership
Warrants
16 - Acquisition or disposition under a prospectus exemption

+200,000 vol
200,000
Filed 2017-01-27
Tx date 2017-01-18
$ATT
Abattis Bioceuticals Corp.
Panenka, William
4 - Director of Issuer
Direct Ownership
Warrants
54 - Exercise of warrants
$-14,000
-200,000 vol
$0.07 each
0
Filed 2017-01-27
Tx date 2016-11-02
$ATT
Abattis Bioceuticals Corp.
Panenka, William
4 - Director of Issuer
Direct Ownership
Warrants
99 - Correction of information

+200,000 vol
400,000
Filed 2017-01-27
Tx date 2017-01-18
$ATT
Abattis Bioceuticals Corp.
Panenka, William
4 - Director of Issuer
Direct Ownership
Common Shares
54 - Exercise of warrants
$40,000,000,000
+200,000 vol
$200,000 each
200,000
Filed 2017-01-26
Tx date 2017-01-23
$ATT
Abattis Bioceuticals Corp.
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Warrants
54 - Exercise of warrants
$21,000
+300,000 vol
$0.07 each
555,556
Filed 2017-01-26
Tx date 2017-01-23
$ATT
Abattis Bioceuticals Corp.
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Warrants
54 - Exercise of warrants
$-21,000
-300,000 vol
$0.07 each
255,556
Filed 2017-01-26
Tx date 2017-01-23
$ATT
Abattis Bioceuticals Corp.
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services
$5,237
+51,852 vol
$0.101 each
6,136,791
Filed 2017-01-23
Tx date 2017-01-17
$ATT
Abattis Bioceuticals Corp.
Xie, Shuang
4 - Director of Issuer
Direct Ownership
Common Shares
46 - Compensation for services
$10,505
+103,704 vol
$0.1013 each
550,392
Filed 2017-01-18
Tx date 2017-01-09
$ATT
Abattis Bioceuticals Corp.
Panenka, William
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-28,000
-200,000 vol
$0.14 each
0
Filed 2017-01-16
Tx date 2017-01-13
$ATT
Abattis Bioceuticals Corp.
Xie, Shuang
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-2,520
-18,000 vol
$0.14 each
446,688
Filed 2017-01-15
Tx date 2017-01-09
$ATT
Abattis Bioceuticals Corp.
David, Rene
5 - Senior Officer of Issuer
Direct Ownership
Warrants
54 - Exercise of warrants

+200,000 vol
0
Filed 2017-01-15
Tx date 2017-01-09
$ATT
Abattis Bioceuticals Corp.
David, Rene
5 - Senior Officer of Issuer
Direct Ownership
Warrants
54 - Exercise of warrants

-200,000 vol
-200,000
Filed 2017-01-15
Tx date 2017-01-12
$ATT
Abattis Bioceuticals Corp.
David, Rene
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-28,000
-200,000 vol
$0.14 each
953,488
Filed 2017-01-15
Tx date 2017-01-12
$ATT
Abattis Bioceuticals Corp.
David, Rene
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$18,000
+200,000 vol
$0.09 each
1,153,488
Filed 2017-01-12
Tx date 2017-01-12
$ATT
Abattis Bioceuticals Corp.
Xie, Shuang
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-23,100
-165,000 vol
$0.14 each
464,688
Filed 2017-01-09
Tx date 2016-08-02
$ATT
Abattis Bioceuticals Corp.
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
36 - Conversion or exchange
$46,259
+925,186 vol
$0.05 each
4,987,343
Filed 2016-12-22
Tx date 2016-12-19
$ATT
Abattis Bioceuticals Corp.
Irving, James
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-18,450
-123,000 vol
$0.15 each
120,750
Filed 2016-12-19
Tx date 2016-12-12
$ATT
Abattis Bioceuticals Corp.
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services
$5,249
+53,846 vol
$0.0975 each
5,159,753
Filed 2016-12-16
Tx date 2016-12-12
$ATT
Abattis Bioceuticals Corp.
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Common Shares
46 - Compensation for services
$5,813
+59,621 vol
$0.0975 each
309,621
Filed 2016-12-14
Tx date 2016-12-12
$ATT
Abattis Bioceuticals Corp.
Xie, Shuang
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$5,249
+53,846 vol
$0.0975 each
629,688
Filed 2016-12-04
Tx date 2016-11-25
$ATT
Abattis Bioceuticals Corp.
Panenka, William
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-14,500
-100,000 vol
$0.145 each
200,000
Filed 2016-11-22
Tx date 2016-11-14
$ATT
Abattis Bioceuticals Corp.
Xie, Shuang
4 - Director of Issuer
Direct Ownership
Common Shares
46 - Compensation for services
$5,250
+43,750 vol
$0.12 each
575,842
Filed 2016-11-22
Tx date 2016-11-14
$ATT
Abattis Bioceuticals Corp.
Xie, Shuang
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
532,092
Filed 2016-11-18
Tx date 2016-11-14
$ATT
Abattis Bioceuticals Corp.
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services
$5,250
+43,750 vol
$0.12 each
5,105,907
Filed 2016-11-17
Tx date 2016-11-15
$ATT
Abattis Bioceuticals Corp.
Panenka, William
4 - Director of Issuer
Direct Ownership
Common Shares
54 - Exercise of warrants
$14,000
+200,000 vol
$0.07 each
300,000
Filed 2016-11-17
Tx date 2016-11-14
$ATT
Abattis Bioceuticals Corp.
Panenka, William
4 - Director of Issuer
Direct Ownership
Common Shares
46 - Compensation for services

+100,000 vol
100,000
Filed 2016-11-17
Tx date 2016-11-02
$ATT
Abattis Bioceuticals Corp.
Panenka, William
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2016-11-17
Tx date 2016-11-14
$ATT
Abattis Bioceuticals Corp.
Irving, James
4 - Director of Issuer
Direct Ownership
Common Shares
46 - Compensation for services

+43,750 vol
243,750
Filed 2016-11-17
Tx date 2016-11-15
$ATT
Abattis Bioceuticals Corp.
Panenka, William
4 - Director of Issuer
Direct Ownership
Warrants
54 - Exercise of warrants
$-14,000
-200,000 vol
$0.07 each
0
Filed 2016-11-07
Tx date 2016-11-02
$ATT
Abattis Bioceuticals Corp.
Panenka, William
4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
200,000
Filed 2016-10-24
Tx date 2016-10-14
$ATT
Abattis Bioceuticals Corp.
Sorocco, Douglas
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$45,000
+250,000 vol
$0.18 each
925,000
Filed 2016-10-24
Tx date 2016-10-14
$ATT
Abattis Bioceuticals Corp.
Irving, James
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$45,000
+250,000 vol
$0.18 each
250,000
Filed 2016-10-24
Tx date 2016-10-14
$ATT
Abattis Bioceuticals Corp.
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Options
50 - Grant of options

+1,750,000 vol
1,750,000
Filed 2016-10-24
Tx date 2016-10-14
$ATT
Abattis Bioceuticals Corp.
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services
$117,800
+950,000 vol
$0.124 each
5,062,157
Filed 2016-10-24
Tx date 2016-10-14
$ATT
Abattis Bioceuticals Corp.
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services
$3,100
+25,000 vol
$0.124 each
4,112,157
Filed 2016-10-24
Tx date 2016-09-20
$ATT
Abattis Bioceuticals Corp.
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services
$1,405
+25,000 vol
$0.0562 each
4,087,157
Filed 2016-10-24
Tx date 2016-08-02
$ATT
Abattis Bioceuticals Corp.
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
16 - Acquisition or disposition under a prospectus exemption
$61,019
+1,220,391 vol
$0.05 each
4,062,157
Filed 2016-10-24
Tx date 2016-07-31
$ATT
Abattis Bioceuticals Corp.
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services
$875.00
+25,000 vol
$0.035 each
2,841,766
Filed 2016-10-24
Tx date 2016-06-30
$ATT
Abattis Bioceuticals Corp.
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services
$875.00
+25,000 vol
$0.035 each
2,816,766
Filed 2016-10-24
Tx date 2015-09-16
$ATT
Abattis Bioceuticals Corp.
Irving, James
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2016-07-25
Tx date 2016-06-30
$ATT
Abattis Bioceuticals Corp.
Yung, Michael David
5 - Senior Officer of Issuer
Holder: 1072915 BC LTD (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$5,416
+135,417 vol
$0.04 each
545,337
Filed 2016-06-15
Tx date 2016-06-15
$ATT
Abattis Bioceuticals Corp.
Yung, Michael David
5 - Senior Officer of Issuer
Holder: 1072915 BC LTD (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$5,416
+108,333 vol
$0.05 each
409,920
Filed 2016-06-06
Tx date 2016-05-24
$ATT
Abattis Bioceuticals Corp.
David, Rene
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$4,500
+100,000 vol
$0.045 each
953,488
Filed 2016-06-01
Tx date 2016-05-31
$ATT
Abattis Bioceuticals Corp.
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services
$1,250
+25,000 vol
$0.05 each
2,791,766
Filed 2016-05-31
Tx date 2016-05-31
$ATT
Abattis Bioceuticals Corp.
Amin Shanjani, Maryam
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$500.00
+10,000 vol
$0.05 each
280,000
Filed 2016-05-27
Tx date 2016-05-19
$ATT
Abattis Bioceuticals Corp.
Amin Shanjani, Maryam
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
270,000
Filed 2016-05-09
Tx date 2016-05-03
$ATT
Abattis Bioceuticals Corp.
Yung, Michael David
5 - Senior Officer of Issuer
Holder: 1072915 BC LTD (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$15,079
+301,587 vol
$0.05 each
301,587
Filed 2016-05-09
Tx date 2016-04-18
$ATT
Abattis Bioceuticals Corp.
Yung, Michael David
5 - Senior Officer of Issuer
Holder: 1072915 BC LTD (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2016-05-06
Tx date 2016-05-03
$ATT
Abattis Bioceuticals Corp.
Irving, James
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$5,000
+100,000 vol
$0.05 each
200,000
Filed 2016-05-06
Tx date 2016-05-03
$ATT
Abattis Bioceuticals Corp.
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services
$1,250
+25,000 vol
$0.05 each
2,766,766
Filed 2016-05-06
Tx date 2016-05-03
$ATT
Abattis Bioceuticals Corp.
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$10,000
+200,000 vol
$0.05 each
250,000
Filed 2016-05-06
Tx date 2014-09-16
$ATT
Abattis Bioceuticals Corp.
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
50,000
Filed 2016-04-13
Tx date 2015-11-16
$ATT
Abattis Bioceuticals Corp.
Irving, James
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$9,000
+100,000 vol
$0.09 each
100,000
Filed 2016-04-13
Tx date 2015-09-16
$ATT
Abattis Bioceuticals Corp.
Irving, James
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2016-04-13
Tx date 2015-11-02
$ATT
Abattis Bioceuticals Corp.
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Options
10 - Acquisition or disposition in the public market
$4,500
+50,000 vol
$0.09 each
450,000
Filed 2016-04-13
Tx date 2015-08-20
$ATT
Abattis Bioceuticals Corp.
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$18,000
+300,000 vol
$0.06 each
400,000
Filed 2016-04-13
Tx date 2014-09-17
$ATT
Abattis Bioceuticals Corp.
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$33,000
+100,000 vol
$0.33 each
100,000
Filed 2016-04-13
Tx date 2014-09-16
$ATT
Abattis Bioceuticals Corp.
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2016-04-08
Tx date 2016-04-08
$ATT
Abattis Bioceuticals Corp.
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$165.00
+3,000 vol
$0.055 each
2,741,766
Filed 2016-04-08
Tx date 2016-04-07
$ATT
Abattis Bioceuticals Corp.
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$9,460
+172,000 vol
$0.055 each
2,738,766
Filed 2016-04-05
Tx date 2016-04-01
$ATT
Abattis Bioceuticals Corp.
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services
$1,500
+25,000 vol
$0.06 each
2,566,766
Filed 2016-03-04
Tx date 2016-02-29
$ATT
Abattis Bioceuticals Corp.
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services

+25,000 vol
2,541,766
Filed 2015-11-12
Tx date 2015-08-19
$ATT
Abattis Bioceuticals Corp.
Fleming, William James
4 - Director of Issuer
Holder: Manewagi Technologies Inc. (Indirect Ownership)
Warrants
16 - Acquisition or disposition under a prospectus exemption
$9,000
+100,000 vol
$0.09 each
100,000
Filed 2015-11-12
Tx date 2014-06-18
$ATT
Abattis Bioceuticals Corp.
Fleming, William James
4 - Director of Issuer
Holder: Manewagi Technologies Inc. (Indirect Ownership)
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2015-11-12
Tx date 2015-08-19
$ATT
Abattis Bioceuticals Corp.
Fleming, William James
4 - Director of Issuer
Direct Ownership
Warrants
16 - Acquisition or disposition under a prospectus exemption
$9,000
+100,000 vol
$0.09 each
Filed 2015-11-12
Tx date 2015-08-19
$ATT
Abattis Bioceuticals Corp.
Fleming, William James
4 - Director of Issuer
Direct Ownership
Warrants
16 - Acquisition or disposition under a prospectus exemption
$9,000
+100,000 vol
$0.09 each
Filed 2015-11-12
Tx date 2015-03-19
$ATT
Abattis Bioceuticals Corp.
Fleming, William James
4 - Director of Issuer
Direct Ownership
Warrants
15 - Acquisition or disposition under a prospectus
$13,846
+76,923 vol
$0.18 each
76,923
Filed 2015-11-12
Tx date 2014-06-18
$ATT
Abattis Bioceuticals Corp.
Fleming, William James
4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2015-11-12
Tx date 2015-08-19
$ATT
Abattis Bioceuticals Corp.
Fleming, William James
4 - Director of Issuer
Holder: Manewagi Technologies Inc. (Indirect Ownership)
Common Shares
16 - Acquisition or disposition under a prospectus exemption
$5,000
+100,000 vol
$0.05 each
100,000
Filed 2015-11-12
Tx date 2014-06-18
$ATT
Abattis Bioceuticals Corp.
Fleming, William James
4 - Director of Issuer
Holder: Manewagi Technologies Inc. (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2015-11-12
Tx date 2015-11-12
$ATT
Abattis Bioceuticals Corp.
Fleming, William James
4 - Director of Issuer
Direct Ownership
Common Shares
46 - Compensation for services
$33,923
+376,923 vol
$0.09 each
376,923
Filed 2015-11-12
Tx date 2015-11-09
$ATT
Abattis Bioceuticals Corp.
Fleming, William James
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-30,153.84
-376,923 vol
$0.08 each
0
Filed 2015-11-12
Tx date 2015-03-19
$ATT
Abattis Bioceuticals Corp.
Fleming, William James
4 - Director of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption
$9,999
+76,923 vol
$0.13 each
376,923
Filed 2015-08-25
Tx date 2015-08-24
$ATT
Abattis Bioceuticals Corp.
Minshew, Brazos Arthur Glenn
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Options
50 - Grant of options
$30,000
+500,000 vol
$0.06 each
500,000
Filed 2015-08-25
Tx date 2014-07-01
$ATT
Abattis Bioceuticals Corp.
Minshew, Brazos Arthur Glenn
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2015-08-25
Tx date 2015-08-20
$ATT
Abattis Bioceuticals Corp.
Fleming, William James
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$42,000
+700,000 vol
$0.06 each
700,000
Filed 2015-08-25
Tx date 2014-06-18
$ATT
Abattis Bioceuticals Corp.
Fleming, William James
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2015-08-24
Tx date 2015-08-20
$ATT
Abattis Bioceuticals Corp.
Sorocco, Douglas
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$18,000
+300,000 vol
$0.06 each
675,000
Filed 2015-08-24
Tx date 2015-08-20
$ATT
Abattis Bioceuticals Corp.
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Options
50 - Grant of options
$42,000
+700,000 vol
$0.06 each
1,885,000
Filed 2015-08-24
Tx date 2015-08-18
$ATT
Abattis Bioceuticals Corp.
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services
$1,750
+25,000 vol
$0.07 each
2,516,766
Filed 2015-07-20
Tx date 2015-07-03
$ATT
Abattis Bioceuticals Corp.
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$7,893
+98,666 vol
$0.08 each
2,491,766
Filed 2015-07-20
Tx date 2015-07-03
$ATT
Abattis Bioceuticals Corp.
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services
$1,625
+25,000 vol
$0.065 each
2,393,100
Filed 2015-07-20
Tx date 2015-06-03
$ATT
Abattis Bioceuticals Corp.
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services
$2,750
+25,000 vol
$0.11 each
2,368,100
Filed 2015-07-20
Tx date 2015-06-03
$ATT
Abattis Bioceuticals Corp.
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services
$27,500
+250,000 vol
$0.11 each
Filed 2015-07-20
Tx date 2015-03-04
$ATT
Abattis Bioceuticals Corp.
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services
$34,375
+196,429 vol
$0.175 each
2,172,985
Filed 2015-07-20
Tx date 2015-05-06
$ATT
Abattis Bioceuticals Corp.
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services
$14,000
+116,667 vol
$0.12 each
2,343,100
Filed 2015-06-03
Tx date 2015-06-03
$ATT
Abattis Bioceuticals Corp.
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services
$27,500
+250,000 vol
$0.11 each
2,280,004